Sengenics Announces New Research Collaboration with GSK Focusing on Immunology

Sengenics, the Functional Proteomics Company, announced today that it has entered into a research collaboration agreement with GlaxoSmithKline (GSK). The collaboration will combine Sengenics’ functional proteomics capabilities with GSK’s scientific expertise in immunology, especially in drug discovery. The collaboration will leverage Sengenics’ proprietary KREX™ technology to validate novel autoantibody biomarkers in patients with autoimmune diseases. […]